Yahoo Finance

Estimated Discount To Fair Value: 34.9%

Exosens, trading at €34.11, is significantly undervalued with a fair value estimate of €52.39 based on discounted cash flow analysis. Despite recent share price volatility, the company's earnings are projected to grow substantially at 23% annually, surpassing the French market average. Recent investments in U.S. production facilities and strong demand for night vision technology underscore Exosens' strategic positioning in defense markets, enhancing its potential for future revenue growth despite slower overall revenue forecasts compared to earnings growth expectations.

• The analysis detailed in our Exosens growth report hints at robust future financial performance.

• Click here to discover the nuances of Exosens with our detailed financial health report.

Yara International

Overview: Yara International ASA is a global provider of crop nutrition and industrial solutions, operating across multiple continents with a market cap of NOK87.40 billion.

Operations: Yara International ASA generates revenue through its segments in Europe ($4.36 billion), Americas ($4.78 billion), Africa & Asia ($2.85 billion), Clean Ammonia ($1.81 billion), Industrial Solutions ($2.42 billion), and Global Plants & Operational Excellence ($2.94 billion).

Estimated Discount To Fair Value: 13%

Yara International, trading at NOK343.1, is undervalued with a fair value estimate of NOK394.33 based on discounted cash flow analysis. Despite high debt levels and a recent net loss of US$290 million for Q4 2024, earnings are forecast to grow significantly at 38.1% annually, outpacing the Norwegian market average. While profit margins have declined, Yara's revenue growth is expected to surpass the local market rate slightly at 3% per year.

• In light of our recent growth report, it seems possible that Yara International's financial performance will exceed current levels.

• Click here and access our complete balance sheet health report to understand the dynamics of Yara International.

Key Takeaways

• Access the full spectrum of 208 Undervalued European Stocks Based On Cash Flows by clicking on this link.

• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CPSE:NETC ENXTPA:EXENS and OB:YAR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com